Clinical development and launch of TLM-003 eye drops to prevent myopia progression
An individual development theme focused on advancing TLM-003 from animal studies to domestic Phase I and Phase II trials and overseas Phase II trials, with the aim of launching it as an eye drop to prevent myopia progression.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.